Market Tracker

02/09 5:16pm ET

Heron Therapeutics Inc (NASDAQ:HRTX)

During the Trading Day
18.76 +1.41 / +8.13%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
18.76 +0.0038 / +0.02%
 
Volume: 1.5K

Today’s Trading

Previous close17.35
Today’s open16.86
Day’s range16.65 - 19.42
Volume1,013,581
Average volume (3 months)824,225
Market cap$624.1M
Dividend yield--
Data as of 4:00pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)+5.01%
Earnings growth (next 5 years)+56.17%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.04

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...+0.02+0.37%
SUPNSupernus Pharmaceuti...-0.41-3.27%
TBPHTheravance Biopharma...-0.69-4.06%
FOLDAmicus Therapeutics ...+0.12+2.33%
Data as of 4:14pm ET, 02/09/2016

Financials

Next reporting dateMarch 28, 2016
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts